Pune, India -- (SBWire) -- 01/18/2018 --Seasonal affective disorder (SAD) is a type of depression or disorder which is related to changes in seasons. SAD frequently happens due to reducing light exposure to sunlight and occurs during a certain time of the year. Women are mostly affected with SAD who aged between 15 to 55 years.
This Report Contains:
- No of Pages: 350
- No of Figures: 60
- No of Tables: 220
Get Free Sample of Global Seasonal Affective Disorder Market Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-seasonal-affective-disorder-market
Segmentation of Global Seasonal Affective Disorder Market
By type the global seasonal affective disorder market is segmented into fall and winter sad, spring and summer sad, others.
On the basis of diagnosis the global seasonal affective disorder market is segmented into physical exams, lab tests, psychological evaluation, others.
On the basis of treatment the global seasonal affective disorder market is segmented into phototherapy, medications, psychotherapy, counseling.
Psychotherapy is further sub segmented into art therapy, attachment-based psychotherapy, behavioral therapy, body psychotherapy, cognitive analytical therapy (cat), existential psychotherapy, gestalt therapy.
On the basis of end user the global seasonal affective disorder market is segmented into hospital, clinics, academic institutes, medical research centers.
On the basis of distribution channel the global seasonal affective disorder market is segmented into hospital pharmacies, retail pharmacies and drug stores, online pharmacies.
On the basis of geography, global seasonal affective disorder market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
View Detail TOC of Global Seasonal Affective Disorder Market report Visit @ http://databridgemarketresearch.com/toc/?dbmr=global-seasonal-affective-disorder-market
Seasonal Affective Disorder Top Companies:
- Janssen Pharmaceuticals, Inc.,
- Pfizer Inc.,
- Merck & Co., Inc.,
- GlaxoSmithKline plc.,
- Sanofi,
- Eli Lilly and Company,
- Biogen,
- Bristol-Myers Squibb Company,
- Baxter,
- ALLARGAN,
- Hoffmann-La Roche Ltd.,
- Henry Schein, Inc.
- Among Others
Browse Detailed of TOC, Inquiry and Analyst call on Global Seasonal Affective Disorder Market Report Visit @: http://databridgemarketresearch.com/reports/global-seasonal-affective-disorder-market/
Related Market Insights:
Global Human Insulin Drugs and Delivery Devices Market – Industry Trends and Forecast to 2024
Global Human Insulin Drugs and Delivery Devices Market, By Product Type, By End-User, By Distribution Channel, By Geography (North America, South America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA)) – Industry Trends and Forecast to 2024
More Insights: http://databridgemarketresearch.com/reports/global-human-insulin-drugs-and-delivery-devices-market/
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/" href="http://databridgemarketresearch.com/blog/"> http://databridgemarketresearch.com/blog/>
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
Health Report 2017: North America Is Expected to Dominate the Seasonal Affective Disorder Market with Solution of New Product Launches and Clinical Results of Products
databridgemarketresearch.com added new report “Global Seasonal Affective Disorder Market“ accounted to USD 520.0 million in 2016 growing at a CAGR of 4.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.